Elin Haf Davies

CEO, Aparito

Position in Extended Committee - Regulatory and clinical trial data expert
Elin Haf Davies

Elin Haf Davies PhD is the CEO of Aparito, a company developed to support the adoption of technology and innovative solutions for monitoring patients in clinical trials and introducing innovative study designs, and data generation strategies. Prior to Aparito, Elin Haf has 18+ years of clinical, academic and regulatory drug development experience. Elin Haf’s PhD focused on developing new endpoints / outcome measure of gait / ataxia in children with neuro-Lysosomal Storage Disorders. She was part of the paediatric team at the European Medicine Agency (EMA) responsible for implementing the EU Paediatric Regulation in 2007. During that time she evaluated over 100 PIPs / waiver requests / Protocol Assistance. 

Disclosure statement:
Dr Davies currently serves as a Consultant for Duchenne UK HERCULES project and Imperial University development of new digital biomarkers.
She has also previously worked with SysNav to seek EMA Qualification of Actimyo